Rabeprazole Adult Dosing
For gastro-oesophageal reflux disease (GERD) and erosive oesophagitis, use rabeprazole 20 mg once daily for 4-8 weeks; for H. pylori eradication, use rabeprazole 20 mg twice daily with amoxicillin 1000 mg and clarithromycin 500 mg for 7 days; no dose adjustment is needed in hepatic impairment. 1
GERD and Erosive Oesophagitis
Acute Treatment
Healing of erosive/ulcerative GERD: 20 mg once daily for 4-8 weeks 1
Symptomatic GERD (non-erosive): 20 mg once daily for up to 4 weeks 1
- If symptoms persist after 4 weeks, consider an additional course 1
Maintenance Therapy
- Maintenance of healing: 20 mg once daily 1
Clinical Context: Rabeprazole demonstrates rapid onset of action compared to other PPIs, achieving optimal acid suppression from the first dose 3, 4. This translates to faster symptom relief, particularly in patients with severe heartburn 5. The drug has a higher pKa (~5.0), allowing activation at higher pH levels more rapidly than other PPIs 3.
Helicobacter Pylori Eradication
Triple therapy regimen 1:
- Rabeprazole 20 mg twice daily
- Amoxicillin 1000 mg twice daily
- Clarithromycin 500 mg twice daily
- Duration: 7 days
- Timing: Take all three medications with morning and evening meals 1
Important considerations:
- High-dose PPIs (40 mg rabeprazole twice daily) may increase H. pylori cure rates by 8-12% compared to standard dosing 6
- For optimal efficacy, consider using 40 mg rabeprazole or esomeprazole twice daily, as these are more potent second-generation PPIs 7
- Extending treatment duration to 10-14 days improves eradication success by approximately 5% 6
- After failure of clarithromycin-containing therapy, do not repeat clarithromycin—switch to bismuth quadruple therapy or alternative regimens 6
Other Indications
Duodenal Ulcers
- Healing: 20 mg once daily after the morning meal for up to 4 weeks 1
- Most patients heal within 4 weeks; some may require additional therapy 1
Pathological Hypersecretory Conditions (Zollinger-Ellison Syndrome)
- Starting dose: 60 mg once daily, then adjust to patient needs 1
- Some patients require divided doses (e.g., 100 mg once daily or 60 mg twice daily) 1
- Continue as long as clinically indicated; some patients treated continuously for up to one year 1
Dose Adjustments
Hepatic Impairment
No dose adjustment is necessary in mild to moderate hepatic impairment 8. Rabeprazole has a predominantly non-enzymatic metabolic pathway, making it less susceptible to hepatic dysfunction compared to other PPIs that rely heavily on CYP2C19 metabolism 3, 9.
Renal Impairment
No dosage adjustment is necessary in renal impairment 8.
Elderly Patients
No specific dose adjustment required; rabeprazole has been studied in patients up to 89 years of age with similar safety profiles 1.
Administration Pearls
- Missed dose: Take as soon as possible. If almost time for next dose, skip the missed dose—do not double up 1
- Tablet integrity: Must swallow whole; crushing or chewing destroys the delayed-release coating 1
- Timing flexibility: Except for duodenal ulcers (take after meals) and H. pylori therapy (take with food), rabeprazole can be taken with or without food for other indications 1
Common Pitfalls to Avoid
Do not use twice-daily dosing empirically for GERD: Standard FDA-approved dosing is once daily; twice-daily dosing is not FDA-approved for GERD and should be reserved for specific situations like H. pylori eradication 1
Avoid repeating failed antibiotics: If clarithromycin-containing H. pylori therapy fails, do not use clarithromycin or other macrolides again 10
Do not discontinue maintenance therapy prematurely in severe esophagitis: Patients with Los Angeles grade C/D erosive esophagitis have high recurrence rates and should remain on continuous therapy 11
Consider PPI potency differences: Rabeprazole 20 mg is equivalent to approximately 36 mg omeprazole, making it one of the more potent PPIs 7